These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 18096386)

  • 61. Entry into a new class of protein kinase inhibitors by pseudo ring design.
    Furet P; Caravatti G; Guagnano V; Lang M; Meyer T; Schoepfer J
    Bioorg Med Chem Lett; 2008 Feb; 18(3):897-900. PubMed ID: 18248988
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Synthesis and biological evaluation of novel 2,4-diaminoquinazoline derivatives as SMN2 promoter activators for the potential treatment of spinal muscular atrophy.
    Thurmond J; Butchbach ME; Palomo M; Pease B; Rao M; Bedell L; Keyvan M; Pai G; Mishra R; Haraldsson M; Andresson T; Bragason G; Thosteinsdottir M; Bjornsson JM; Coovert DD; Burghes AH; Gurney ME; Singh J
    J Med Chem; 2008 Feb; 51(3):449-69. PubMed ID: 18205293
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Montelukast inhibition of resting and GM-CSF-stimulated eosinophil adhesion to VCAM-1 under flow conditions appears independent of cysLT(1)R antagonism.
    Robinson AJ; Kashanin D; O'Dowd F; Williams V; Walsh GM
    J Leukoc Biol; 2008 Jun; 83(6):1522-9. PubMed ID: 18332235
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Synthesis and structure-activity relationships for biphenyl H3 receptor antagonists with moderate anti-cholinesterase activity.
    Morini G; Comini M; Rivara M; Rivara S; Bordi F; Plazzi PV; Flammini L; Saccani F; Bertoni S; Ballabeni V; Barocelli E; Mor M
    Bioorg Med Chem; 2008 Dec; 16(23):9911-24. PubMed ID: 18976927
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Discovery and optimization of substituted piperidines as potent, selective, CNS-penetrant alpha4beta2 nicotinic acetylcholine receptor potentiators.
    Albrecht BK; Berry V; Boezio AA; Cao L; Clarkin K; Guo W; Harmange JC; Hierl M; Huang L; Janosky B; Knop J; Malmberg A; McDermott JS; Nguyen HQ; Springer SK; Waldon D; Woodin K; McDonough SI
    Bioorg Med Chem Lett; 2008 Oct; 18(19):5209-12. PubMed ID: 18789861
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Discovery and stereoselective synthesis of the novel isochroman neurokinin-1 receptor antagonist 'CJ-17,493'.
    Shishido Y; Wakabayashi H; Koike H; Ueno N; Nukui S; Yamagishi T; Murata Y; Naganeo F; Mizutani M; Shimada K; Fujiwara Y; Sakakibara A; Suga O; Kusano R; Ueda S; Kanai Y; Tsuchiya M; Satake K
    Bioorg Med Chem; 2008 Aug; 16(15):7193-205. PubMed ID: 18640044
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Discovery of potent, selective, and orally active carboxylic acid based inhibitors of matrix metalloproteinase-13.
    Monovich LG; Tommasi RA; Fujimoto RA; Blancuzzi V; Clark K; Cornell WD; Doti R; Doughty J; Fang J; Farley D; Fitt J; Ganu V; Goldberg R; Goldstein R; Lavoie S; Kulathila R; Macchia W; Parker DT; Melton R; O'Byrne E; Pastor G; Pellas T; Quadros E; Reel N; Roland DM; Sakane Y; Singh H; Skiles J; Somers J; Toscano K; Wigg A; Zhou S; Zhu L; Shieh WC; Xue S; McQuire LW
    J Med Chem; 2009 Jun; 52(11):3523-38. PubMed ID: 19422229
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Discovery of 1-[9-(4-chlorophenyl)-8-(2-chlorophenyl)-9H-purin-6-yl]-4-ethylaminopiperidine-4-carboxylic acid amide hydrochloride (CP-945,598), a novel, potent, and selective cannabinoid type 1 receptor antagonist.
    Griffith DA; Hadcock JR; Black SC; Iredale PA; Carpino PA; DaSilva-Jardine P; Day R; DiBrino J; Dow RL; Landis MS; O'Connor RE; Scott DO
    J Med Chem; 2009 Jan; 52(2):234-7. PubMed ID: 19102698
    [TBL] [Abstract][Full Text] [Related]  

  • 69. SA13353 (1-[2-(1-Adamantyl)ethyl]-1-pentyl-3-[3-(4-pyridyl)propyl]urea) inhibits TNF-alpha production through the activation of capsaicin-sensitive afferent neurons mediated via transient receptor potential vanilloid 1 in vivo.
    Murai M; Tsuji F; Nose M; Seki I; Oki K; Setoguchi C; Suhara H; Sasano M; Aono H
    Eur J Pharmacol; 2008 Jul; 588(2-3):309-15. PubMed ID: 18508045
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Attractive strain: the disadvantages of rigid multiple H-bond donors and acceptors. A theoretical analysis of the hydrogen-bonding interactions in complexes of tetraazaanthracenedione with pyridylureas.
    Oliva A; Bertran J; Dannenberg JJ
    J Phys Chem B; 2008 Feb; 112(6):1765-9. PubMed ID: 18211062
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Soluble vascular cell adhesion molecule-1 induces human eosinophil migration.
    Ueki S; Kihara J; Kato H; Ito W; Takeda M; Kobayashi Y; Kayaba H; Chihara J
    Allergy; 2009 May; 64(5):718-24. PubMed ID: 19210349
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Inhibitors of GlyT1 affect glycine transport via discrete binding sites.
    Mezler M; Hornberger W; Mueller R; Schmidt M; Amberg W; Braje W; Ochse M; Schoemaker H; Behl B
    Mol Pharmacol; 2008 Dec; 74(6):1705-15. PubMed ID: 18815213
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Spiropiperidine CCR5 antagonists.
    Rotstein DM; Gabriel SD; Makra F; Filonova L; Gleason S; Brotherton-Pleiss C; Setti LQ; Trejo-Martin A; Lee EK; Sankuratri S; Ji C; Derosier A; Dioszegi M; Heilek G; Jekle A; Berry P; Weller P; Mau CI
    Bioorg Med Chem Lett; 2009 Sep; 19(18):5401-6. PubMed ID: 19674898
    [TBL] [Abstract][Full Text] [Related]  

  • 74. 2-Cycloalkyl phenoxyacetic acid CRTh2 receptor antagonists.
    Sandham DA; Aldcroft C; Baettig U; Barker L; Beer D; Bhalay G; Brown Z; Dubois G; Budd D; Bidlake L; Campbell E; Cox B; Everatt B; Harrison D; Leblanc CJ; Manini J; Profit R; Stringer R; Thompson KS; Turner KL; Tweed MF; Walker C; Watson SJ; Whitebread S; Willis J; Williams G; Wilson C
    Bioorg Med Chem Lett; 2007 Aug; 17(15):4347-50. PubMed ID: 17531480
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Involvement of eosinophils in the onset of asthma.
    Matsumoto K; Tamari M; Saito H
    J Allergy Clin Immunol; 2008 Jan; 121(1):26-7. PubMed ID: 18061649
    [No Abstract]   [Full Text] [Related]  

  • 76. 6-amino-4-oxo-1,3-diphenyl-2-thioxo-1,2,3,4-tetrahydropyrimidine-5-carbonyl derivatives as a new class of potent inhibitors of Interleukin-8-induced neutrophil chemotaxis.
    Cesarini S; Spallarossa A; Ranise A; Bruno O; Arduino N; Bertolotto M; Dallegri F; Tognolini M; Gobbetti T; Barocelli E
    Bioorg Med Chem; 2009 May; 17(10):3580-7. PubMed ID: 19394230
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Guest exchange in dimeric capsules formed by tetra-urea calix[4]arenes.
    Vatsouro I; Alt E; Vysotsky M; Böhmer V
    Org Biomol Chem; 2008 Mar; 6(6):998-1003. PubMed ID: 18327324
    [TBL] [Abstract][Full Text] [Related]  

  • 78. APD791, 3-methoxy-n-(3-(1-methyl-1h-pyrazol-5-yl)-4-(2-morpholinoethoxy)phenyl)benzamide, a novel 5-hydroxytryptamine 2A receptor antagonist: pharmacological profile, pharmacokinetics, platelet activity and vascular biology.
    Adams JW; Ramirez J; Shi Y; Thomsen W; Frazer J; Morgan M; Edwards JE; Chen W; Teegarden BR; Xiong Y; Al-Shamma H; Behan DP; Connolly DT
    J Pharmacol Exp Ther; 2009 Oct; 331(1):96-103. PubMed ID: 19628629
    [TBL] [Abstract][Full Text] [Related]  

  • 79. On the inhibition of HIV-1 protease by hydrazino-ureas displaying the N-->C=O interaction.
    Waibel M; Pitrat D; Hasserodt J
    Bioorg Med Chem; 2009 May; 17(10):3671-9. PubMed ID: 19394228
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Discovery of novel, potent and bioavailable proline-urea based macrocyclic HCV NS3/4A protease inhibitors.
    Vendeville S; Nilsson M; de Kock H; Lin TI; Antonov D; Classon B; Ayesa S; Ivanov V; Johansson PO; Kahnberg P; Eneroth A; Wikstrom K; Vrang L; Edlund M; Lindström S; Van de Vreken W; McGowan D; Tahri A; Hu L; Lenz O; Delouvroy F; Van Dooren M; Kindermans N; Surleraux D; Wigerinck P; Rosenquist A; Samuelsson B; Simmen K; Raboisson P
    Bioorg Med Chem Lett; 2008 Dec; 18(23):6189-93. PubMed ID: 18954982
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.